The Extent of Tumor in the Peritoneum and Liver Influences Outcomes After Surgery for Synchronous Liver and Peritoneal Colorectal Metastases: A Cohort Study.

ABSTRACT:

Purpose

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRSH) or liver resection have led to increased survival in patients with peritoneal or liver metastases of colorectal cancer. Selected patients undergo concomitant CRSH and liver resection. Differences in survival and morbidity between patients who underwent concomitant surgery, CRSH or liver resection for peritoneal and/or liver metastases were compared.

Methods

Patients who underwent liver resection and/or CRSH for colorectal liver and/or peritoneal metastases, 2006-2016, were included. Regression analysis was used to evaluate the associations between baseline characteristics and survival.

Results

Overall, 634 patients were studied. Twenty-eight patients had peritoneal and liver metastases,

SUBMITTER: Salas PS 

PROVIDER: S-EPMC11561098 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature